One example is triple negative breast cancer (TNBC), which accounts for 15% of all diagnosed breast carcinomas and is characterized by a lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression (Waks and Winer, 2019). Here, ERBB2 is linked to breast carcinoma.